binge eating disorder glp 1 GLP-1 Therapy: An Emerging Tool in Psychiatry Neurobiological Mechanisms and Therapeutic Potential

The data shows differences, but mechanism matters more: Research shows interesting differences between medications

Tirzepatide (Mounjaro) Dual-action weight loss medication that targets both GLP-1 & GIP receptors More powerful appetite suppression and metabolism support than Semaglutide FDA-approved for diabetes and in clinical trials for weight loss Patients lose up to 20-30% of their body weight How It Works: Tirzepatide combines GLP-1 and GIP receptor agonists , which work together to control appetite, regulate insulin, and improve fat metabolismresulting in greater and faster weight loss

B.Glin.et al (2022)

Ecotoxicol Environ Saf 236:113437 Soussana JF, Loiseau P, Vuichard N, Ceschia E, Balesdent J, Chevallier T, Arrouays D (2004) Carbon cycling and sequestration opportunities in temperate grasslands

Im trying to think of a non-gruesome example